0.2824
3.18%
0.0087
Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten
Are Lyra Therapeutics Inc (LYRA) shares a good deal now? - US Post News
Ratio Revelations: Lyra Therapeutics Inc (LYRA)’s Financial Metrics in the Spotlight - The Dwinnex
The Psychology of Lyra Therapeutics Inc Inc. (LYRA) Price Performance: Understanding Market Sentiment - The InvestChronicle
Taking the lead: Lyra Therapeutics Inc (LYRA) - SETE News
Lyra Therapeutics Inc (LYRA) stock analysis: A simple moving average approach - US Post News
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Given Consensus Rating of “Hold” by Analysts - Defense World
Lyra Therapeutics Inc (LYRA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
The growth track for Lyra Therapeutics Inc (LYRA) has changed recently - SETE News
Gaining Ground: Lyra Therapeutics Inc (LYRA) Closes Lower at 0.29, Down -4.01 - The Dwinnex
Is it possible to buy Lyra Therapeutics Inc(LYRA) shares at a good price now? - US Post News
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Short Interest Up 18.6% in August - Defense World
A better buy-in window may exist right now for Lyra Therapeutics Inc (LYRA) - SETE News
Was anything negative for Lyra Therapeutics Inc (LYRA) stock last session? - US Post News
Company’s Banking Stock: Dissecting a 5.19% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Despite Recent Gains, Lyra Therapeutics Insiders Are Still Down US$66k - Simply Wall St
Lyra Therapeutics Insiders Still US$66k Away From Original Investment Value - Yahoo Finance
Sinusitis Market to Exhibit Moderate Growth Rate till - openPR
The LYRA Stock Puzzle: Unraveling Lyra Therapeutics Inc’s Fluctuating Performance - The InvestChronicle
Nothing is Better Than Lyra Therapeutics Inc (LYRA) stock at the moment - SETE News
Lyra Therapeutics Inc (LYRA)’s stock chart: A technical perspective - US Post News
Market Highlights: Lyra Therapeutics Inc (LYRA) Ends on a High Note at 0.30 - The Dwinnex
William Blair Brokers Increase Earnings Estimates for Lyra Therapeutics, Inc. (NASDAQ:LYRA) - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Rating Reiterated by Cantor Fitzgerald - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Reaffirmed by HC Wainwright - Defense World
Vanguard Group Inc. Raises Holdings in Lyra Therapeutics, Inc. (NASDAQ:LYRA) - Defense World
Lyra Therapeutics Inc (LYRA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
H.C. Wainwright holds Lyra Therapeutics stock at 'Neutral,' awaiting Phase 3 results - Investing.com Canada
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Given Average Rating of “Hold” by Brokerages - Defense World
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Beats Revenue for Q2 2024 - MSN
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Finance
Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - StockTitan
Closing Figures Unveiled: Lyra Therapeutics Inc (LYRA) Drop -1.02, Closes at 0.30 - The Dwinnex
Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
There is no doubt that Lyra Therapeutics Inc (LYRA) ticks all the boxes. - SETE News
Lyra Therapeutics Inc (LYRA)’s stock price range in the last year - US Post News
The Future of Lyra Therapeutics Inc: Analyzing LYRA - The InvestChronicle
Financial Metrics Exploration: Understanding Lyra Therapeutics Inc (LYRA) Through Ratios - The Dwinnex
Ratios Uncovered: Breaking Down Lyra Therapeutics Inc (LYRA)’s Trailing Twelve Months Metrics - The Dwinnex
What is Lyra Therapeutics Inc (LYRA) Stock Return on Shareholders’ Capital? - SETE News
Lyra Therapeutics Inc (LYRA) produces promising results - US Post News
There is no way Lyra Therapeutics Inc (LYRA) can keep these numbers up - SETE News
Lyra Therapeutics Inc (LYRA) is a good investment, but the stock may be undervalued - US Post News
Investor’s Delight: Lyra Therapeutics Inc (LYRA) Closes Weak at 0.28, Down -3.08 - The Dwinnex
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Receives Average Recommendation of “Hold” from Analysts - Defense World
Lyra Therapeutics Inc (LYRA) can make a big difference with a little luck - SETE News
Lyra Therapeutics, Inc. (LYRA): A Good Penny Stock to Buy For Under $1? - Insider Monkey
Lyra Therapeutics, Inc. (LYRA): A Good Penny Stock to Buy For Under $1? - Yahoo Finance
Lyra Therapeutics Inc (LYRA)’s results reveal risk - US Post News
10 Best Penny Stocks to Buy Under $1 - Insider Monkey
Market Momentum: Lyra Therapeutics Inc (LYRA) Registers a -0.34 Decrease, Closing at 0.29 - The Dwinnex
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff - BioSpace
Lyra Therapeutics Inc (LYRA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):